April 2026 Ashland continued expanding its specialty cellulose portfolio by advancing differentiated cellulose grades for pharmaceutical and industrial applications. The company highlighted continued innovation in cellulose-based excipients, including solutions used in drug formulation and other specialty applications.
February 2026 Ashland continued strengthening its cellulose ether business through product innovation initiatives focused on specialty grades and application-specific solutions. The company emphasized development of cellulose derivatives supporting pharmaceutical, personal care, and industrial formulation requirements.
November 2025 Shin-Etsu Chemical continued advancing its cellulose ether product portfolio, including hydroxypropyl methylcellulose (HPMC) solutions used in pharmaceutical formulations, construction materials, and industrial applications. The company continued focusing on high-performance cellulose derivatives for global markets.
September 2025 Dow continued developing cellulose ether-based solutions through its specialty materials portfolio, supporting applications such as construction additives, coatings, and formulated products. The company continued focusing on performance-enhancing polymers and sustainable material solutions.